Page last updated: 2024-11-03

propidium and Hepatolenticular Degeneration

propidium has been researched along with Hepatolenticular Degeneration in 1 studies

Propidium: Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits.

Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.

Research Excerpts

ExcerptRelevanceReference
"Wilson's disease is a genetic disorder characterized by the accumulation of copper in the body due to a defect of biliary copper excretion."1.31Copper does not alter the intracellular distribution of ATP7B, a copper-transporting ATPase. ( Baba, S; Furuta, K; Hanada, S; Harada, M; Kawaguchi, T; Kimura, R; Koga, H; Kumashiro, R; Sakisaka, S; Sata, M; Sugiyama, T; Taniguchi, E, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harada, M1
Sakisaka, S1
Kawaguchi, T1
Kimura, R1
Taniguchi, E1
Koga, H1
Hanada, S1
Baba, S1
Furuta, K1
Kumashiro, R1
Sugiyama, T1
Sata, M1

Other Studies

1 other study available for propidium and Hepatolenticular Degeneration

ArticleYear
Copper does not alter the intracellular distribution of ATP7B, a copper-transporting ATPase.
    Biochemical and biophysical research communications, 2000, Sep-07, Volume: 275, Issue:3

    Topics: Adenosine Triphosphatases; Antigens, CD; Biological Transport; Biomarkers; Carcinoma, Hepatocellular

2000